A new weapon for attacking tumor blood vessels

Gregg L. Semenza

doi:10.1056/NEJMcibr0800272

A new weapon for attacking tumor blood vessels

Gregg L. Semenza

School of Medicine

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

The vascular endothelial growth factor is the target of the antiangiogenic drug bevacizumab. Another protein, placental growth factor, also represents a promising target for countering tumor angiogenesis.

Original language	English (US)
Pages (from-to)	2066
Number of pages	1
Journal	New England Journal of Medicine
Volume	358
Issue number	19
DOIs	https://doi.org/10.1056/NEJMcibr0800272
State	Published - May 8 2008

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMcibr0800272

Cite this

@article{2c0491357c0a4ce88eda066a43739117,

title = "A new weapon for attacking tumor blood vessels",

abstract = "The vascular endothelial growth factor is the target of the antiangiogenic drug bevacizumab. Another protein, placental growth factor, also represents a promising target for countering tumor angiogenesis.",

author = "Semenza, {Gregg L.}",

year = "2008",

month = may,

day = "8",

doi = "10.1056/NEJMcibr0800272",

language = "English (US)",

volume = "358",

pages = "2066",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "19",

}

TY - JOUR

T1 - A new weapon for attacking tumor blood vessels

AU - Semenza, Gregg L.

PY - 2008/5/8

Y1 - 2008/5/8

N2 - The vascular endothelial growth factor is the target of the antiangiogenic drug bevacizumab. Another protein, placental growth factor, also represents a promising target for countering tumor angiogenesis.

AB - The vascular endothelial growth factor is the target of the antiangiogenic drug bevacizumab. Another protein, placental growth factor, also represents a promising target for countering tumor angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=43249114808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249114808&partnerID=8YFLogxK

U2 - 10.1056/NEJMcibr0800272

DO - 10.1056/NEJMcibr0800272

M3 - Article

C2 - 18463385

AN - SCOPUS:43249114808

SN - 0028-4793

VL - 358

SP - 2066

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 19

ER -

A new weapon for attacking tumor blood vessels

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this